logo
Select company
Select metric
46.08%Cash Return on Invested Capital
VS
Market
98
Sector
99
Industry
99
History
98
$ 30.27Close
$ 13.63 - $ 41.99 52-Week Range
Ticker Information

Ticker

RIGL

Company Name

RIGEL PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

RIGEL PHARMACEUTICALS INC - Cash Return on Invested Capital Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RIGL - CROIC Historical data
DateCash Return on Invested CapitalFree Cash FlowInvested Capital
6/30/202546.08%$ 65.89M$ 142.98M
3/31/202544.49%$ 35.43M$ 79.63M
12/31/202449.28%$ 31.17M$ 63.25M
9/30/202423.02%$ 10.49M$ 45.59M
6/30/2024-41.22%$ -12.54M$ 30.42M
3/31/2024-23.2%$ -6.69M$ 28.83M
12/31/2023-17.17%$ -5.48M$ 31.93M
9/30/2023-72.46%$ -20.99M$ 28.96M
6/30/2023-100.94%$ -32.86M$ 32.55M
3/31/2023-140.91%$ -51.4M$ 36.48M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • RIGEL PHARMACEUTICALS INC's latest trailing twelve months (TTM) CROIC stands at -51.74%.
  • Over the past 5 years, RIGEL PHARMACEUTICALS INC's average CROIC has been -59.27%.
  • The median CROIC for RIGEL PHARMACEUTICALS INC during this period was -32.21%
  • RIGEL PHARMACEUTICALS INC reached its highest CROIC over the past 5 years at 49.28%.
  • The lowest CROIC recorded by RIGEL PHARMACEUTICALS INC in the same timeframe -308.3%

RIGEL PHARMACEUTICALS INC's CROIC vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CROIC Benchmarks
CompanyCROIC
MRVI : MARAVAI LIFESCIENCES HOLDINGS INC -6.87%KROS : KEROS THERAPEUTICS INC 7.32%ARVN : ARVINAS INC -64.44%RGNX : REGENXBIO INC -18.69%VNDA : VANDA PHARMACEUTICALS INC -13.36%CTMX : CYTOMX THERAPEUTICS INC -61.26%XNCR : XENCOR INC -16.24%ESPR : ESPERION THERAPEUTICS INC -75.6%NKTR : NEKTAR THERAPEUTICS -167.75%PBYI : PUMA BIOTECHNOLOGY INC 28.73%

Definition of Cash Return on Invested Capital

[Calculation] Cash Return on Invested Capital (CROIC) measures how well a company uses its invested capital to produce cash. It is calculated as Free Cash Flow [FCF] divided by invested capital [InvCapital].
FCF / Inv. Capital
(=) CROIC
CROIC for RIGEL PHARMACEUTICALS INC is calculated as follows: FCF [ $ -47.63M ] / Inv. Capital [ $ 92.05M ]
(=) CROIC [ -51.74% ]

RIGL - Cash Return on Invested Capital, Last 5 years

-308.3%

Minimum

Sep 30, 2022

49.28%

Maximum

Dec 31, 2024

-59.27%

Average

-32.21%

Median

CROIC Benchmark Analysis

The chart above depicts the distribution of CROIC for companies in the Total Stock Market. The average CROIC of the companies is 2.82% with a standard deviation of 15.01%.
The following table provides additional summary stats:
CROIC in the Market:
filtered constituents3.46K
min-43.7%
max49.3%
average2.82%
median4.98%
std15.01%